SEC
Filing

SEC Filing Details

Document Details

Filing Date
Feb 16, 2021
Document Date
Feb 16, 2021
Form Description
An amendment to the SC 13G filing
Filing Group
Other
Company
Altimmune
Issuer
ALTIMMUNE, INC.
 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe